Nicholas Gulati

15PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical social work practiceMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 20, 2024
Efficacy of ChatGPT in Educating Patients and Clinicians About Skin Toxicities Associated With Cancer Treatment.

Annie Chang, Jade Young, Andrew Para

|Apr 22, 2024
A Survey of Demographics and Treatments in Melanoma Case Reports: Retrospective Bibliometric Analysis.

Ross O'Hagan, Jessie Ngandjui, Benjamin Ungar

|Aug 26, 2023
Medicare Opt-Out Trends Among Dermatologists May Reflect Systemic Health Policy: Cross-sectional Analysis.

Aneesh Agarwal, Joseph Han, Yen Luu

|Dec 29, 2022
Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.

Joseph Han, Scott Stratman, Jade N Young

|Oct 14, 2021
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors.

Nicholas Gulati, Arda Celen, Paul Johannet

|Nov 12, 2020
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors.

Nicholas Gulati, Douglas Donnelly, Yingzhi Qian

Pageof 3

Frequent Collaborators

5 joint publications

Ross O'Hagan

5 joint publications

Benjamin Ungar

5 joint publications

Jonathan Ungar

4 joint publications

Joseph Han